Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mullerian inhibiting substance binding and uptake.

E A Catlin1, R M Ezzell, P K Donahoe

  • 1Division of Neonatal and Pediatric Intensive Care, Massachusetts General Hospital, Boston 02114.

Developmental Dynamics : an Official Publication of the American Association of Anatomists
|April 1, 1992
PubMed
Summary

Mullerian inhibiting substance (MIS) binds to a specific protein on the cell surface, initiating its function in male fetal development. This binding is crucial for understanding MIS action and potential therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.

Current molecular medicine·2016
Same author

An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance.

Technology (Elmsford, N.Y.)·2014
Same author

Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia.

Clinical genetics·2014
Same author

Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.

Theriogenology·2008
Same author

Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome.

American journal of medical genetics. Part A·2005
Same author

Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology.

Human reproduction (Oxford, England)·2005

Area of Science:

  • Reproductive Biology
  • Developmental Biology
  • Endocrinology

Background:

  • Mullerian inhibiting substance (MIS) is a glycoprotein from Sertoli cells.
  • MIS plays a critical role in male fetal development.
  • Its function is presumed to be initiated by ligand-receptor binding.

Purpose of the Study:

  • To identify and localize the binding species for MIS.
  • To investigate the mechanism of MIS action in fetal tissues.

Main Methods:

  • Incubation of cultured fetal rat lungs and urogenital ridge tissues with MIS.
  • Immunofluorescence labeling using anti-MIS IgG and fluorescein-conjugated secondary antibodies.
  • Laser confocal microscopy for visualization.
  • Crosslinking of 125I-MIS with plasma membranes.

Related Experiment Videos

Main Results:

  • Punctate surface fluorescence followed by cytosolic and nuclear localization in lung tissue, suggesting adsorptive endocytosis.
  • MIS binding was observed on the Mullerian duct in the urogenital ridge.
  • Plasma membrane crosslinking identified a high molecular mass MIS binder, displaceable by unlabeled MIS.

Conclusions:

  • A specific plasma membrane binding protein for MIS exists.
  • These findings support the hypothesis of a specific receptor mediating MIS function.
  • The study provides insights into the cellular mechanisms of MIS action during male development.